A randomised controlled trial to evaluate the peri-operative role of intraoperative dexmedetomidine infusion in robotic-assisted laparoscopic oncosurgeries
Conclusion: Intraoperative dexmed (bolus of 1 μg/kg followed by 0.2 μg/kg/h infusion) has an opioid and inhalational anaesthetic sparing role during robotic oncosurgeries. However, no benefit of the infusion is seen in the postoperative period.
Source: Indian Journal of Anaesthesia - Category: Anesthesiology Authors: Sumitra G Bakshi Susan V Paulin Pranay Bhawalkar Source Type: research
More News: Anesthesia | Anesthesiology | Computers | Fentanyl | India Health | Laparoscopy | Medical Ethics | Pain | Study